nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—PPP3CA—Cyclosporine—rheumatoid arthritis	0.26	0.447	CbGbCtD
Tacrolimus—ALB—rheumatoid arthritis	0.122	1	CbGaD
Tacrolimus—FKBP1A—Cyclosporine—rheumatoid arthritis	0.108	0.186	CbGbCtD
Tacrolimus—ALB—Auranofin—rheumatoid arthritis	0.0324	0.0556	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Hydrocortisone—rheumatoid arthritis	0.0111	0.019	CbGbCtD
Tacrolimus—CYP3A7—Hydrocortisone—rheumatoid arthritis	0.0111	0.019	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Cyclosporine—rheumatoid arthritis	0.0105	0.018	CbGbCtD
Tacrolimus—CYP3A7—Cyclosporine—rheumatoid arthritis	0.0105	0.018	CbGbCtD
Tacrolimus—CYP3A5—Sulfasalazine—rheumatoid arthritis	0.0104	0.0178	CbGbCtD
Tacrolimus—ALB—Prednisone—rheumatoid arthritis	0.0103	0.0177	CbGbCtD
Tacrolimus—ABCB1—Methylprednisolone—rheumatoid arthritis	0.0089	0.0153	CbGbCtD
Tacrolimus—CYP3A5—Hydrocortisone—rheumatoid arthritis	0.00832	0.0143	CbGbCtD
Tacrolimus—CYP3A5—Cyclosporine—rheumatoid arthritis	0.00786	0.0135	CbGbCtD
Tacrolimus—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.00723	0.0124	CbGbCtD
Tacrolimus—CYP3A7-CYP3A51P—Dexamethasone—rheumatoid arthritis	0.0069	0.0118	CbGbCtD
Tacrolimus—CYP3A7—Dexamethasone—rheumatoid arthritis	0.0069	0.0118	CbGbCtD
Tacrolimus—ABCB1—Betamethasone—rheumatoid arthritis	0.00579	0.00994	CbGbCtD
Tacrolimus—ABCB1—Prednisolone—rheumatoid arthritis	0.00571	0.00981	CbGbCtD
Tacrolimus—ABCB1—Hydrocortisone—rheumatoid arthritis	0.00541	0.0093	CbGbCtD
Tacrolimus—ABCB1—Prednisone—rheumatoid arthritis	0.00539	0.00926	CbGbCtD
Tacrolimus—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.00533	0.00916	CbGbCtD
Tacrolimus—CYP3A5—Dexamethasone—rheumatoid arthritis	0.00517	0.00888	CbGbCtD
Tacrolimus—ALB—Methotrexate—rheumatoid arthritis	0.00517	0.00888	CbGbCtD
Tacrolimus—ABCB1—Cyclosporine—rheumatoid arthritis	0.00511	0.00878	CbGbCtD
Tacrolimus—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00404	0.00694	CbGbCtD
Tacrolimus—CYP3A4—Betamethasone—rheumatoid arthritis	0.00347	0.00595	CbGbCtD
Tacrolimus—CYP3A4—Prednisolone—rheumatoid arthritis	0.00342	0.00588	CbGbCtD
Tacrolimus—ABCB1—Dexamethasone—rheumatoid arthritis	0.00337	0.00578	CbGbCtD
Tacrolimus—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00324	0.00557	CbGbCtD
Tacrolimus—CYP3A4—Prednisone—rheumatoid arthritis	0.00323	0.00555	CbGbCtD
Tacrolimus—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00306	0.00526	CbGbCtD
Tacrolimus—ABCB1—Methotrexate—rheumatoid arthritis	0.00271	0.00465	CbGbCtD
Tacrolimus—ORM1—saliva—rheumatoid arthritis	0.00232	0.133	CbGeAlD
Tacrolimus—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00202	0.00346	CbGbCtD
Tacrolimus—ABCA5—parotid gland—rheumatoid arthritis	0.00174	0.0995	CbGeAlD
Tacrolimus—ABCA5—saliva-secreting gland—rheumatoid arthritis	0.00166	0.0953	CbGeAlD
Tacrolimus—PPP3CA—parotid gland—rheumatoid arthritis	0.00117	0.0672	CbGeAlD
Tacrolimus—PPP3CA—saliva-secreting gland—rheumatoid arthritis	0.00112	0.0643	CbGeAlD
Tacrolimus—ABCA5—tendon—rheumatoid arthritis	0.00105	0.0602	CbGeAlD
Tacrolimus—PPP3CA—connective tissue—rheumatoid arthritis	0.00103	0.0591	CbGeAlD
Tacrolimus—MTOR—connective tissue—rheumatoid arthritis	0.000763	0.0437	CbGeAlD
Tacrolimus—PPP3CA—lymphoid tissue—rheumatoid arthritis	0.000755	0.0432	CbGeAlD
Tacrolimus—PPP3CA—digestive system—rheumatoid arthritis	0.000746	0.0427	CbGeAlD
Tacrolimus—PPP3CA—tendon—rheumatoid arthritis	0.00071	0.0406	CbGeAlD
Tacrolimus—FKBP1A—connective tissue—rheumatoid arthritis	0.000686	0.0393	CbGeAlD
Tacrolimus—MTOR—lymphoid tissue—rheumatoid arthritis	0.000558	0.0319	CbGeAlD
Tacrolimus—MTOR—digestive system—rheumatoid arthritis	0.000551	0.0315	CbGeAlD
Tacrolimus—MTOR—tendon—rheumatoid arthritis	0.000524	0.03	CbGeAlD
Tacrolimus—FKBP1A—lymphoid tissue—rheumatoid arthritis	0.000502	0.0287	CbGeAlD
Tacrolimus—FKBP1A—digestive system—rheumatoid arthritis	0.000496	0.0284	CbGeAlD
Tacrolimus—FKBP1A—tendon—rheumatoid arthritis	0.000472	0.027	CbGeAlD
Tacrolimus—CYP3A5—digestive system—rheumatoid arthritis	0.000216	0.0124	CbGeAlD
Tacrolimus—CYP3A4—digestive system—rheumatoid arthritis	0.000162	0.00927	CbGeAlD
Tacrolimus—ABCB1—lymphoid tissue—rheumatoid arthritis	0.000116	0.00664	CbGeAlD
Tacrolimus—ABCB1—digestive system—rheumatoid arthritis	0.000115	0.00656	CbGeAlD
Tacrolimus—Pharyngitis—Methotrexate—rheumatoid arthritis	3.35e-05	0.000185	CcSEcCtD
Tacrolimus—Nausea—Leflunomide—rheumatoid arthritis	3.34e-05	0.000184	CcSEcCtD
Tacrolimus—Urinary tract disorder—Methotrexate—rheumatoid arthritis	3.33e-05	0.000184	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	3.33e-05	0.000184	CcSEcCtD
Tacrolimus—Fatigue—Hydrocortisone—rheumatoid arthritis	3.32e-05	0.000183	CcSEcCtD
Tacrolimus—Vision blurred—Prednisone—rheumatoid arthritis	3.31e-05	0.000183	CcSEcCtD
Tacrolimus—Urethral disorder—Methotrexate—rheumatoid arthritis	3.31e-05	0.000183	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	3.31e-05	0.000183	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	3.3e-05	0.000182	CcSEcCtD
Tacrolimus—Pain—Hydrocortisone—rheumatoid arthritis	3.29e-05	0.000182	CcSEcCtD
Tacrolimus—Anaphylactic shock—Betamethasone—rheumatoid arthritis	3.29e-05	0.000182	CcSEcCtD
Tacrolimus—Oedema—Dexamethasone—rheumatoid arthritis	3.29e-05	0.000182	CcSEcCtD
Tacrolimus—Oedema—Betamethasone—rheumatoid arthritis	3.29e-05	0.000182	CcSEcCtD
Tacrolimus—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	3.29e-05	0.000182	CcSEcCtD
Tacrolimus—Insomnia—Triamcinolone—rheumatoid arthritis	3.28e-05	0.000181	CcSEcCtD
Tacrolimus—Insomnia—Methylprednisolone—rheumatoid arthritis	3.27e-05	0.000181	CcSEcCtD
Tacrolimus—Infection—Dexamethasone—rheumatoid arthritis	3.27e-05	0.000181	CcSEcCtD
Tacrolimus—Infection—Betamethasone—rheumatoid arthritis	3.27e-05	0.000181	CcSEcCtD
Tacrolimus—Ill-defined disorder—Prednisone—rheumatoid arthritis	3.26e-05	0.00018	CcSEcCtD
Tacrolimus—Paraesthesia—Triamcinolone—rheumatoid arthritis	3.26e-05	0.00018	CcSEcCtD
Tacrolimus—Feeling abnormal—Prednisolone—rheumatoid arthritis	3.25e-05	0.00018	CcSEcCtD
Tacrolimus—Paraesthesia—Methylprednisolone—rheumatoid arthritis	3.25e-05	0.00018	CcSEcCtD
Tacrolimus—Visual impairment—Methotrexate—rheumatoid arthritis	3.25e-05	0.000179	CcSEcCtD
Tacrolimus—Anaemia—Prednisone—rheumatoid arthritis	3.25e-05	0.000179	CcSEcCtD
Tacrolimus—Shock—Dexamethasone—rheumatoid arthritis	3.24e-05	0.000179	CcSEcCtD
Tacrolimus—Shock—Betamethasone—rheumatoid arthritis	3.24e-05	0.000179	CcSEcCtD
Tacrolimus—Dyspnoea—Triamcinolone—rheumatoid arthritis	3.23e-05	0.000179	CcSEcCtD
Tacrolimus—Nervous system disorder—Dexamethasone—rheumatoid arthritis	3.23e-05	0.000178	CcSEcCtD
Tacrolimus—Nervous system disorder—Betamethasone—rheumatoid arthritis	3.23e-05	0.000178	CcSEcCtD
Tacrolimus—Agitation—Prednisone—rheumatoid arthritis	3.23e-05	0.000178	CcSEcCtD
Tacrolimus—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	3.22e-05	0.000178	CcSEcCtD
Tacrolimus—Thrombocytopenia—Betamethasone—rheumatoid arthritis	3.22e-05	0.000178	CcSEcCtD
Tacrolimus—Tachycardia—Dexamethasone—rheumatoid arthritis	3.21e-05	0.000177	CcSEcCtD
Tacrolimus—Tachycardia—Betamethasone—rheumatoid arthritis	3.21e-05	0.000177	CcSEcCtD
Tacrolimus—Hypersensitivity—Cyclosporine—rheumatoid arthritis	3.19e-05	0.000176	CcSEcCtD
Tacrolimus—Dyspepsia—Triamcinolone—rheumatoid arthritis	3.19e-05	0.000176	CcSEcCtD
Tacrolimus—Erythema multiforme—Methotrexate—rheumatoid arthritis	3.19e-05	0.000176	CcSEcCtD
Tacrolimus—Dyspepsia—Methylprednisolone—rheumatoid arthritis	3.19e-05	0.000176	CcSEcCtD
Tacrolimus—Hyperhidrosis—Betamethasone—rheumatoid arthritis	3.18e-05	0.000176	CcSEcCtD
Tacrolimus—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	3.18e-05	0.000176	CcSEcCtD
Tacrolimus—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	3.18e-05	0.000175	CcSEcCtD
Tacrolimus—Malaise—Prednisone—rheumatoid arthritis	3.17e-05	0.000175	CcSEcCtD
Tacrolimus—Vertigo—Prednisone—rheumatoid arthritis	3.16e-05	0.000174	CcSEcCtD
Tacrolimus—Eye disorder—Methotrexate—rheumatoid arthritis	3.15e-05	0.000174	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	3.15e-05	0.000174	CcSEcCtD
Tacrolimus—Syncope—Prednisone—rheumatoid arthritis	3.15e-05	0.000174	CcSEcCtD
Tacrolimus—Tinnitus—Methotrexate—rheumatoid arthritis	3.14e-05	0.000174	CcSEcCtD
Tacrolimus—Anorexia—Betamethasone—rheumatoid arthritis	3.14e-05	0.000173	CcSEcCtD
Tacrolimus—Anorexia—Dexamethasone—rheumatoid arthritis	3.14e-05	0.000173	CcSEcCtD
Tacrolimus—Urticaria—Prednisolone—rheumatoid arthritis	3.13e-05	0.000173	CcSEcCtD
Tacrolimus—Cardiac disorder—Methotrexate—rheumatoid arthritis	3.13e-05	0.000173	CcSEcCtD
Tacrolimus—Fatigue—Triamcinolone—rheumatoid arthritis	3.13e-05	0.000173	CcSEcCtD
Tacrolimus—Fatigue—Methylprednisolone—rheumatoid arthritis	3.12e-05	0.000172	CcSEcCtD
Tacrolimus—Asthenia—Cyclosporine—rheumatoid arthritis	3.11e-05	0.000172	CcSEcCtD
Tacrolimus—Pain—Triamcinolone—rheumatoid arthritis	3.1e-05	0.000171	CcSEcCtD
Tacrolimus—Loss of consciousness—Prednisone—rheumatoid arthritis	3.09e-05	0.000171	CcSEcCtD
Tacrolimus—Hypotension—Dexamethasone—rheumatoid arthritis	3.08e-05	0.00017	CcSEcCtD
Tacrolimus—Hypotension—Betamethasone—rheumatoid arthritis	3.08e-05	0.00017	CcSEcCtD
Tacrolimus—Pruritus—Cyclosporine—rheumatoid arthritis	3.07e-05	0.000169	CcSEcCtD
Tacrolimus—Urticaria—Hydrocortisone—rheumatoid arthritis	3.06e-05	0.000169	CcSEcCtD
Tacrolimus—Angiopathy—Methotrexate—rheumatoid arthritis	3.06e-05	0.000169	CcSEcCtD
Tacrolimus—Immune system disorder—Methotrexate—rheumatoid arthritis	3.05e-05	0.000168	CcSEcCtD
Tacrolimus—Body temperature increased—Hydrocortisone—rheumatoid arthritis	3.05e-05	0.000168	CcSEcCtD
Tacrolimus—Abdominal pain—Hydrocortisone—rheumatoid arthritis	3.05e-05	0.000168	CcSEcCtD
Tacrolimus—Convulsion—Prednisone—rheumatoid arthritis	3.04e-05	0.000168	CcSEcCtD
Tacrolimus—Mediastinal disorder—Methotrexate—rheumatoid arthritis	3.04e-05	0.000168	CcSEcCtD
Tacrolimus—Hypertension—Prednisone—rheumatoid arthritis	3.03e-05	0.000167	CcSEcCtD
Tacrolimus—Chills—Methotrexate—rheumatoid arthritis	3.03e-05	0.000167	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	3e-05	0.000166	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	3e-05	0.000166	CcSEcCtD
Tacrolimus—Arthralgia—Prednisone—rheumatoid arthritis	2.99e-05	0.000165	CcSEcCtD
Tacrolimus—Myalgia—Prednisone—rheumatoid arthritis	2.99e-05	0.000165	CcSEcCtD
Tacrolimus—Feeling abnormal—Triamcinolone—rheumatoid arthritis	2.99e-05	0.000165	CcSEcCtD
Tacrolimus—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	2.98e-05	0.000165	CcSEcCtD
Tacrolimus—Anxiety—Prednisone—rheumatoid arthritis	2.98e-05	0.000165	CcSEcCtD
Tacrolimus—Alopecia—Methotrexate—rheumatoid arthritis	2.98e-05	0.000165	CcSEcCtD
Tacrolimus—Insomnia—Dexamethasone—rheumatoid arthritis	2.98e-05	0.000164	CcSEcCtD
Tacrolimus—Insomnia—Betamethasone—rheumatoid arthritis	2.98e-05	0.000164	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	2.97e-05	0.000164	CcSEcCtD
Tacrolimus—Diarrhoea—Cyclosporine—rheumatoid arthritis	2.97e-05	0.000164	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	2.96e-05	0.000163	CcSEcCtD
Tacrolimus—Paraesthesia—Betamethasone—rheumatoid arthritis	2.96e-05	0.000163	CcSEcCtD
Tacrolimus—Paraesthesia—Dexamethasone—rheumatoid arthritis	2.96e-05	0.000163	CcSEcCtD
Tacrolimus—Discomfort—Prednisone—rheumatoid arthritis	2.95e-05	0.000163	CcSEcCtD
Tacrolimus—Mental disorder—Methotrexate—rheumatoid arthritis	2.95e-05	0.000163	CcSEcCtD
Tacrolimus—Erythema—Methotrexate—rheumatoid arthritis	2.94e-05	0.000162	CcSEcCtD
Tacrolimus—Malnutrition—Methotrexate—rheumatoid arthritis	2.94e-05	0.000162	CcSEcCtD
Tacrolimus—Hypersensitivity—Prednisolone—rheumatoid arthritis	2.91e-05	0.000161	CcSEcCtD
Tacrolimus—Dyspepsia—Betamethasone—rheumatoid arthritis	2.9e-05	0.00016	CcSEcCtD
Tacrolimus—Dyspepsia—Dexamethasone—rheumatoid arthritis	2.9e-05	0.00016	CcSEcCtD
Tacrolimus—Urticaria—Triamcinolone—rheumatoid arthritis	2.88e-05	0.000159	CcSEcCtD
Tacrolimus—Urticaria—Methylprednisolone—rheumatoid arthritis	2.88e-05	0.000159	CcSEcCtD
Tacrolimus—Dysgeusia—Methotrexate—rheumatoid arthritis	2.87e-05	0.000159	CcSEcCtD
Tacrolimus—Body temperature increased—Triamcinolone—rheumatoid arthritis	2.87e-05	0.000158	CcSEcCtD
Tacrolimus—Dizziness—Cyclosporine—rheumatoid arthritis	2.87e-05	0.000158	CcSEcCtD
Tacrolimus—Oedema—Prednisone—rheumatoid arthritis	2.87e-05	0.000158	CcSEcCtD
Tacrolimus—Anaphylactic shock—Prednisone—rheumatoid arthritis	2.87e-05	0.000158	CcSEcCtD
Tacrolimus—Abdominal pain—Methylprednisolone—rheumatoid arthritis	2.86e-05	0.000158	CcSEcCtD
Tacrolimus—Decreased appetite—Betamethasone—rheumatoid arthritis	2.86e-05	0.000158	CcSEcCtD
Tacrolimus—Decreased appetite—Dexamethasone—rheumatoid arthritis	2.86e-05	0.000158	CcSEcCtD
Tacrolimus—Infection—Prednisone—rheumatoid arthritis	2.85e-05	0.000157	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	2.84e-05	0.000157	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	2.84e-05	0.000157	CcSEcCtD
Tacrolimus—Back pain—Methotrexate—rheumatoid arthritis	2.84e-05	0.000157	CcSEcCtD
Tacrolimus—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	2.84e-05	0.000157	CcSEcCtD
Tacrolimus—Fatigue—Betamethasone—rheumatoid arthritis	2.84e-05	0.000157	CcSEcCtD
Tacrolimus—Fatigue—Dexamethasone—rheumatoid arthritis	2.84e-05	0.000157	CcSEcCtD
Tacrolimus—Shock—Prednisone—rheumatoid arthritis	2.82e-05	0.000156	CcSEcCtD
Tacrolimus—Pain—Dexamethasone—rheumatoid arthritis	2.82e-05	0.000155	CcSEcCtD
Tacrolimus—Pain—Betamethasone—rheumatoid arthritis	2.82e-05	0.000155	CcSEcCtD
Tacrolimus—Nervous system disorder—Prednisone—rheumatoid arthritis	2.81e-05	0.000155	CcSEcCtD
Tacrolimus—Tachycardia—Prednisone—rheumatoid arthritis	2.8e-05	0.000155	CcSEcCtD
Tacrolimus—Skin disorder—Prednisone—rheumatoid arthritis	2.78e-05	0.000154	CcSEcCtD
Tacrolimus—Hyperhidrosis—Prednisone—rheumatoid arthritis	2.77e-05	0.000153	CcSEcCtD
Tacrolimus—Vision blurred—Methotrexate—rheumatoid arthritis	2.77e-05	0.000153	CcSEcCtD
Tacrolimus—Asthenia—Hydrocortisone—rheumatoid arthritis	2.76e-05	0.000153	CcSEcCtD
Tacrolimus—Vomiting—Cyclosporine—rheumatoid arthritis	2.76e-05	0.000152	CcSEcCtD
Tacrolimus—Rash—Cyclosporine—rheumatoid arthritis	2.73e-05	0.000151	CcSEcCtD
Tacrolimus—Anorexia—Prednisone—rheumatoid arthritis	2.73e-05	0.000151	CcSEcCtD
Tacrolimus—Dermatitis—Cyclosporine—rheumatoid arthritis	2.73e-05	0.000151	CcSEcCtD
Tacrolimus—Pruritus—Hydrocortisone—rheumatoid arthritis	2.73e-05	0.000151	CcSEcCtD
Tacrolimus—Ill-defined disorder—Methotrexate—rheumatoid arthritis	2.72e-05	0.00015	CcSEcCtD
Tacrolimus—Headache—Cyclosporine—rheumatoid arthritis	2.72e-05	0.00015	CcSEcCtD
Tacrolimus—Anaemia—Methotrexate—rheumatoid arthritis	2.71e-05	0.00015	CcSEcCtD
Tacrolimus—Feeling abnormal—Betamethasone—rheumatoid arthritis	2.71e-05	0.00015	CcSEcCtD
Tacrolimus—Feeling abnormal—Dexamethasone—rheumatoid arthritis	2.71e-05	0.00015	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	2.69e-05	0.000149	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	2.69e-05	0.000149	CcSEcCtD
Tacrolimus—Hypersensitivity—Triamcinolone—rheumatoid arthritis	2.67e-05	0.000148	CcSEcCtD
Tacrolimus—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	2.67e-05	0.000147	CcSEcCtD
Tacrolimus—Malaise—Methotrexate—rheumatoid arthritis	2.65e-05	0.000146	CcSEcCtD
Tacrolimus—Vertigo—Methotrexate—rheumatoid arthritis	2.64e-05	0.000146	CcSEcCtD
Tacrolimus—Diarrhoea—Hydrocortisone—rheumatoid arthritis	2.64e-05	0.000146	CcSEcCtD
Tacrolimus—Leukopenia—Methotrexate—rheumatoid arthritis	2.63e-05	0.000145	CcSEcCtD
Tacrolimus—Urticaria—Betamethasone—rheumatoid arthritis	2.62e-05	0.000144	CcSEcCtD
Tacrolimus—Urticaria—Dexamethasone—rheumatoid arthritis	2.62e-05	0.000144	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	2.61e-05	0.000144	CcSEcCtD
Tacrolimus—Dizziness—Prednisolone—rheumatoid arthritis	2.61e-05	0.000144	CcSEcCtD
Tacrolimus—Asthenia—Triamcinolone—rheumatoid arthritis	2.6e-05	0.000144	CcSEcCtD
Tacrolimus—Abdominal pain—Dexamethasone—rheumatoid arthritis	2.6e-05	0.000144	CcSEcCtD
Tacrolimus—Body temperature increased—Betamethasone—rheumatoid arthritis	2.6e-05	0.000144	CcSEcCtD
Tacrolimus—Abdominal pain—Betamethasone—rheumatoid arthritis	2.6e-05	0.000144	CcSEcCtD
Tacrolimus—Body temperature increased—Dexamethasone—rheumatoid arthritis	2.6e-05	0.000144	CcSEcCtD
Tacrolimus—Asthenia—Methylprednisolone—rheumatoid arthritis	2.6e-05	0.000143	CcSEcCtD
Tacrolimus—Insomnia—Prednisone—rheumatoid arthritis	2.59e-05	0.000143	CcSEcCtD
Tacrolimus—Nausea—Cyclosporine—rheumatoid arthritis	2.58e-05	0.000142	CcSEcCtD
Tacrolimus—Paraesthesia—Prednisone—rheumatoid arthritis	2.57e-05	0.000142	CcSEcCtD
Tacrolimus—Pruritus—Triamcinolone—rheumatoid arthritis	2.57e-05	0.000142	CcSEcCtD
Tacrolimus—Cough—Methotrexate—rheumatoid arthritis	2.56e-05	0.000141	CcSEcCtD
Tacrolimus—Pruritus—Methylprednisolone—rheumatoid arthritis	2.56e-05	0.000141	CcSEcCtD
Tacrolimus—Dizziness—Hydrocortisone—rheumatoid arthritis	2.55e-05	0.000141	CcSEcCtD
Tacrolimus—Convulsion—Methotrexate—rheumatoid arthritis	2.54e-05	0.00014	CcSEcCtD
Tacrolimus—Dyspepsia—Prednisone—rheumatoid arthritis	2.52e-05	0.000139	CcSEcCtD
Tacrolimus—Chest pain—Methotrexate—rheumatoid arthritis	2.5e-05	0.000138	CcSEcCtD
Tacrolimus—Arthralgia—Methotrexate—rheumatoid arthritis	2.5e-05	0.000138	CcSEcCtD
Tacrolimus—Myalgia—Methotrexate—rheumatoid arthritis	2.5e-05	0.000138	CcSEcCtD
Tacrolimus—Decreased appetite—Prednisone—rheumatoid arthritis	2.49e-05	0.000138	CcSEcCtD
Tacrolimus—Rash—Prednisolone—rheumatoid arthritis	2.49e-05	0.000137	CcSEcCtD
Tacrolimus—Dermatitis—Prednisolone—rheumatoid arthritis	2.49e-05	0.000137	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	2.48e-05	0.000137	CcSEcCtD
Tacrolimus—Diarrhoea—Methylprednisolone—rheumatoid arthritis	2.48e-05	0.000137	CcSEcCtD
Tacrolimus—Fatigue—Prednisone—rheumatoid arthritis	2.47e-05	0.000137	CcSEcCtD
Tacrolimus—Headache—Prednisolone—rheumatoid arthritis	2.47e-05	0.000137	CcSEcCtD
Tacrolimus—Discomfort—Methotrexate—rheumatoid arthritis	2.47e-05	0.000136	CcSEcCtD
Tacrolimus—Constipation—Prednisone—rheumatoid arthritis	2.45e-05	0.000135	CcSEcCtD
Tacrolimus—Vomiting—Hydrocortisone—rheumatoid arthritis	2.45e-05	0.000135	CcSEcCtD
Tacrolimus—Rash—Hydrocortisone—rheumatoid arthritis	2.43e-05	0.000134	CcSEcCtD
Tacrolimus—Dermatitis—Hydrocortisone—rheumatoid arthritis	2.43e-05	0.000134	CcSEcCtD
Tacrolimus—Confusional state—Methotrexate—rheumatoid arthritis	2.42e-05	0.000133	CcSEcCtD
Tacrolimus—Headache—Hydrocortisone—rheumatoid arthritis	2.41e-05	0.000133	CcSEcCtD
Tacrolimus—Dizziness—Triamcinolone—rheumatoid arthritis	2.4e-05	0.000133	CcSEcCtD
Tacrolimus—Anaphylactic shock—Methotrexate—rheumatoid arthritis	2.4e-05	0.000132	CcSEcCtD
Tacrolimus—Dizziness—Methylprednisolone—rheumatoid arthritis	2.39e-05	0.000132	CcSEcCtD
Tacrolimus—Infection—Methotrexate—rheumatoid arthritis	2.38e-05	0.000131	CcSEcCtD
Tacrolimus—Feeling abnormal—Prednisone—rheumatoid arthritis	2.36e-05	0.00013	CcSEcCtD
Tacrolimus—Asthenia—Dexamethasone—rheumatoid arthritis	2.36e-05	0.00013	CcSEcCtD
Tacrolimus—Asthenia—Betamethasone—rheumatoid arthritis	2.36e-05	0.00013	CcSEcCtD
Tacrolimus—Nervous system disorder—Methotrexate—rheumatoid arthritis	2.35e-05	0.00013	CcSEcCtD
Tacrolimus—Thrombocytopenia—Methotrexate—rheumatoid arthritis	2.35e-05	0.00013	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Prednisone—rheumatoid arthritis	2.34e-05	0.000129	CcSEcCtD
Tacrolimus—Nausea—Prednisolone—rheumatoid arthritis	2.34e-05	0.000129	CcSEcCtD
Tacrolimus—Pruritus—Dexamethasone—rheumatoid arthritis	2.33e-05	0.000129	CcSEcCtD
Tacrolimus—Pruritus—Betamethasone—rheumatoid arthritis	2.33e-05	0.000129	CcSEcCtD
Tacrolimus—Skin disorder—Methotrexate—rheumatoid arthritis	2.33e-05	0.000129	CcSEcCtD
Tacrolimus—Hyperhidrosis—Methotrexate—rheumatoid arthritis	2.32e-05	0.000128	CcSEcCtD
Tacrolimus—Vomiting—Triamcinolone—rheumatoid arthritis	2.31e-05	0.000127	CcSEcCtD
Tacrolimus—Vomiting—Methylprednisolone—rheumatoid arthritis	2.3e-05	0.000127	CcSEcCtD
Tacrolimus—Nausea—Hydrocortisone—rheumatoid arthritis	2.29e-05	0.000126	CcSEcCtD
Tacrolimus—Rash—Triamcinolone—rheumatoid arthritis	2.29e-05	0.000126	CcSEcCtD
Tacrolimus—Dermatitis—Triamcinolone—rheumatoid arthritis	2.29e-05	0.000126	CcSEcCtD
Tacrolimus—Anorexia—Methotrexate—rheumatoid arthritis	2.28e-05	0.000126	CcSEcCtD
Tacrolimus—Rash—Methylprednisolone—rheumatoid arthritis	2.28e-05	0.000126	CcSEcCtD
Tacrolimus—Dermatitis—Methylprednisolone—rheumatoid arthritis	2.28e-05	0.000126	CcSEcCtD
Tacrolimus—Urticaria—Prednisone—rheumatoid arthritis	2.28e-05	0.000126	CcSEcCtD
Tacrolimus—Headache—Triamcinolone—rheumatoid arthritis	2.27e-05	0.000126	CcSEcCtD
Tacrolimus—Headache—Methylprednisolone—rheumatoid arthritis	2.27e-05	0.000125	CcSEcCtD
Tacrolimus—Body temperature increased—Prednisone—rheumatoid arthritis	2.27e-05	0.000125	CcSEcCtD
Tacrolimus—Abdominal pain—Prednisone—rheumatoid arthritis	2.27e-05	0.000125	CcSEcCtD
Tacrolimus—Diarrhoea—Betamethasone—rheumatoid arthritis	2.25e-05	0.000124	CcSEcCtD
Tacrolimus—Diarrhoea—Dexamethasone—rheumatoid arthritis	2.25e-05	0.000124	CcSEcCtD
Tacrolimus—Hypotension—Methotrexate—rheumatoid arthritis	2.24e-05	0.000124	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	2.18e-05	0.000121	CcSEcCtD
Tacrolimus—Dizziness—Dexamethasone—rheumatoid arthritis	2.18e-05	0.00012	CcSEcCtD
Tacrolimus—Dizziness—Betamethasone—rheumatoid arthritis	2.18e-05	0.00012	CcSEcCtD
Tacrolimus—Insomnia—Methotrexate—rheumatoid arthritis	2.17e-05	0.00012	CcSEcCtD
Tacrolimus—Nausea—Triamcinolone—rheumatoid arthritis	2.15e-05	0.000119	CcSEcCtD
Tacrolimus—Paraesthesia—Methotrexate—rheumatoid arthritis	2.15e-05	0.000119	CcSEcCtD
Tacrolimus—Nausea—Methylprednisolone—rheumatoid arthritis	2.15e-05	0.000119	CcSEcCtD
Tacrolimus—Dyspnoea—Methotrexate—rheumatoid arthritis	2.14e-05	0.000118	CcSEcCtD
Tacrolimus—Somnolence—Methotrexate—rheumatoid arthritis	2.13e-05	0.000118	CcSEcCtD
Tacrolimus—Hypersensitivity—Prednisone—rheumatoid arthritis	2.11e-05	0.000117	CcSEcCtD
Tacrolimus—Dyspepsia—Methotrexate—rheumatoid arthritis	2.11e-05	0.000116	CcSEcCtD
Tacrolimus—Vomiting—Dexamethasone—rheumatoid arthritis	2.09e-05	0.000116	CcSEcCtD
Tacrolimus—Vomiting—Betamethasone—rheumatoid arthritis	2.09e-05	0.000116	CcSEcCtD
Tacrolimus—Decreased appetite—Methotrexate—rheumatoid arthritis	2.08e-05	0.000115	CcSEcCtD
Tacrolimus—Rash—Betamethasone—rheumatoid arthritis	2.08e-05	0.000115	CcSEcCtD
Tacrolimus—Rash—Dexamethasone—rheumatoid arthritis	2.08e-05	0.000115	CcSEcCtD
Tacrolimus—Dermatitis—Dexamethasone—rheumatoid arthritis	2.07e-05	0.000115	CcSEcCtD
Tacrolimus—Dermatitis—Betamethasone—rheumatoid arthritis	2.07e-05	0.000115	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	2.07e-05	0.000114	CcSEcCtD
Tacrolimus—Fatigue—Methotrexate—rheumatoid arthritis	2.07e-05	0.000114	CcSEcCtD
Tacrolimus—Headache—Betamethasone—rheumatoid arthritis	2.06e-05	0.000114	CcSEcCtD
Tacrolimus—Headache—Dexamethasone—rheumatoid arthritis	2.06e-05	0.000114	CcSEcCtD
Tacrolimus—Asthenia—Prednisone—rheumatoid arthritis	2.06e-05	0.000114	CcSEcCtD
Tacrolimus—Pain—Methotrexate—rheumatoid arthritis	2.05e-05	0.000113	CcSEcCtD
Tacrolimus—Pruritus—Prednisone—rheumatoid arthritis	2.03e-05	0.000112	CcSEcCtD
Tacrolimus—Feeling abnormal—Methotrexate—rheumatoid arthritis	1.97e-05	0.000109	CcSEcCtD
Tacrolimus—Diarrhoea—Prednisone—rheumatoid arthritis	1.96e-05	0.000108	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	1.96e-05	0.000108	CcSEcCtD
Tacrolimus—Nausea—Dexamethasone—rheumatoid arthritis	1.96e-05	0.000108	CcSEcCtD
Tacrolimus—Nausea—Betamethasone—rheumatoid arthritis	1.96e-05	0.000108	CcSEcCtD
Tacrolimus—Urticaria—Methotrexate—rheumatoid arthritis	1.9e-05	0.000105	CcSEcCtD
Tacrolimus—Dizziness—Prednisone—rheumatoid arthritis	1.9e-05	0.000105	CcSEcCtD
Tacrolimus—Body temperature increased—Methotrexate—rheumatoid arthritis	1.89e-05	0.000105	CcSEcCtD
Tacrolimus—Abdominal pain—Methotrexate—rheumatoid arthritis	1.89e-05	0.000105	CcSEcCtD
Tacrolimus—Vomiting—Prednisone—rheumatoid arthritis	1.82e-05	0.000101	CcSEcCtD
Tacrolimus—Rash—Prednisone—rheumatoid arthritis	1.81e-05	9.98e-05	CcSEcCtD
Tacrolimus—Dermatitis—Prednisone—rheumatoid arthritis	1.81e-05	9.97e-05	CcSEcCtD
Tacrolimus—Headache—Prednisone—rheumatoid arthritis	1.8e-05	9.92e-05	CcSEcCtD
Tacrolimus—Hypersensitivity—Methotrexate—rheumatoid arthritis	1.77e-05	9.75e-05	CcSEcCtD
Tacrolimus—Asthenia—Methotrexate—rheumatoid arthritis	1.72e-05	9.49e-05	CcSEcCtD
Tacrolimus—Nausea—Prednisone—rheumatoid arthritis	1.7e-05	9.41e-05	CcSEcCtD
Tacrolimus—Pruritus—Methotrexate—rheumatoid arthritis	1.7e-05	9.36e-05	CcSEcCtD
Tacrolimus—Diarrhoea—Methotrexate—rheumatoid arthritis	1.64e-05	9.05e-05	CcSEcCtD
Tacrolimus—Dizziness—Methotrexate—rheumatoid arthritis	1.58e-05	8.75e-05	CcSEcCtD
Tacrolimus—Vomiting—Methotrexate—rheumatoid arthritis	1.52e-05	8.41e-05	CcSEcCtD
Tacrolimus—Rash—Methotrexate—rheumatoid arthritis	1.51e-05	8.34e-05	CcSEcCtD
Tacrolimus—Dermatitis—Methotrexate—rheumatoid arthritis	1.51e-05	8.34e-05	CcSEcCtD
Tacrolimus—Headache—Methotrexate—rheumatoid arthritis	1.5e-05	8.29e-05	CcSEcCtD
Tacrolimus—Nausea—Methotrexate—rheumatoid arthritis	1.42e-05	7.86e-05	CcSEcCtD
Tacrolimus—MTOR—Signaling Pathways—NFATC1—rheumatoid arthritis	1.22e-05	0.000126	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL6ST—rheumatoid arthritis	1.22e-05	0.000126	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CSF2—rheumatoid arthritis	1.21e-05	0.000125	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—VCAM1—rheumatoid arthritis	1.21e-05	0.000125	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-DQA1—rheumatoid arthritis	1.2e-05	0.000124	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—IL6R—rheumatoid arthritis	1.2e-05	0.000124	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—PRKCQ—rheumatoid arthritis	1.2e-05	0.000124	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—SLC25A12—rheumatoid arthritis	1.19e-05	0.000123	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—NFKB1—rheumatoid arthritis	1.19e-05	0.000123	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PRKCQ—rheumatoid arthritis	1.18e-05	0.000122	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—MAPK8—rheumatoid arthritis	1.17e-05	0.000121	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CD80—rheumatoid arthritis	1.17e-05	0.000121	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ALOX5—rheumatoid arthritis	1.17e-05	0.000121	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCR6—rheumatoid arthritis	1.17e-05	0.000121	CbGpPWpGaD
Tacrolimus—MTOR—Disease—STAT1—rheumatoid arthritis	1.16e-05	0.00012	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PTGES—rheumatoid arthritis	1.16e-05	0.00012	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GC—rheumatoid arthritis	1.16e-05	0.00012	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PLD4—rheumatoid arthritis	1.15e-05	0.000119	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—TYK2—rheumatoid arthritis	1.15e-05	0.000119	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—TP53—rheumatoid arthritis	1.15e-05	0.000118	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—SPP1—rheumatoid arthritis	1.14e-05	0.000117	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NCF2—rheumatoid arthritis	1.13e-05	0.000117	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-DQB1—rheumatoid arthritis	1.13e-05	0.000116	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—POMC—rheumatoid arthritis	1.11e-05	0.000115	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ACAN—rheumatoid arthritis	1.11e-05	0.000115	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SH2B3—rheumatoid arthritis	1.11e-05	0.000114	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TRAF6—rheumatoid arthritis	1.11e-05	0.000114	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CCR5—rheumatoid arthritis	1.11e-05	0.000114	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—GZMB—rheumatoid arthritis	1.1e-05	0.000114	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—MED1—rheumatoid arthritis	1.1e-05	0.000114	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—TYK2—rheumatoid arthritis	1.1e-05	0.000113	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CCL2—rheumatoid arthritis	1.09e-05	0.000113	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL2RA—rheumatoid arthritis	1.09e-05	0.000113	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PTK2—rheumatoid arthritis	1.09e-05	0.000113	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL6R—rheumatoid arthritis	1.09e-05	0.000112	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—C3—rheumatoid arthritis	1.08e-05	0.000112	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PLB1—rheumatoid arthritis	1.08e-05	0.000112	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—NOS3—rheumatoid arthritis	1.08e-05	0.000111	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—rheumatoid arthritis	1.07e-05	0.000111	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL1A—rheumatoid arthritis	1.07e-05	0.000111	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL18—rheumatoid arthritis	1.07e-05	0.00011	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCL3—rheumatoid arthritis	1.07e-05	0.00011	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CXCL2—rheumatoid arthritis	1.07e-05	0.00011	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—FADS2—rheumatoid arthritis	1.06e-05	0.00011	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD40LG—rheumatoid arthritis	1.06e-05	0.00011	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD8A—rheumatoid arthritis	1.05e-05	0.000109	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CSF2—rheumatoid arthritis	1.05e-05	0.000109	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—IL6—rheumatoid arthritis	1.05e-05	0.000108	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—SLC25A12—rheumatoid arthritis	1.05e-05	0.000108	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SAA1—rheumatoid arthritis	1.04e-05	0.000108	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CD4—rheumatoid arthritis	1.04e-05	0.000107	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—AGER—rheumatoid arthritis	1.03e-05	0.000106	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NCF1—rheumatoid arthritis	1.02e-05	0.000106	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ACP5—rheumatoid arthritis	1.02e-05	0.000106	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—B3GNT2—rheumatoid arthritis	1.02e-05	0.000106	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—PTK2—rheumatoid arthritis	1.02e-05	0.000105	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GC—rheumatoid arthritis	1.02e-05	0.000105	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PTGES—rheumatoid arthritis	1.02e-05	0.000105	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-B—rheumatoid arthritis	1.01e-05	0.000105	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—IL2—rheumatoid arthritis	1.01e-05	0.000104	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—LEP—rheumatoid arthritis	1.01e-05	0.000104	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD4—rheumatoid arthritis	9.96e-06	0.000103	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—CD4—rheumatoid arthritis	9.91e-06	0.000102	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TYK2—rheumatoid arthritis	9.9e-06	0.000102	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—CSF2—rheumatoid arthritis	9.85e-06	0.000102	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—PTGS2—rheumatoid arthritis	9.84e-06	0.000102	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—IL6—rheumatoid arthritis	9.83e-06	0.000102	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CD28—rheumatoid arthritis	9.83e-06	0.000102	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—NOS3—rheumatoid arthritis	9.72e-06	0.0001	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ENO1—rheumatoid arthritis	9.55e-06	9.87e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—FN1—rheumatoid arthritis	9.49e-06	9.8e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL2RA—rheumatoid arthritis	9.48e-06	9.8e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—MED1—rheumatoid arthritis	9.46e-06	9.78e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PLB1—rheumatoid arthritis	9.46e-06	9.78e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL6ST—rheumatoid arthritis	9.45e-06	9.76e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—C3—rheumatoid arthritis	9.4e-06	9.71e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-A—rheumatoid arthritis	9.37e-06	9.69e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	9.31e-06	9.63e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—UBE2D1—rheumatoid arthritis	9.25e-06	9.56e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—BGN—rheumatoid arthritis	9.2e-06	9.51e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—TGFB1—rheumatoid arthritis	9.18e-06	9.48e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	9.16e-06	9.46e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CD80—rheumatoid arthritis	9.09e-06	9.4e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CXCL12—rheumatoid arthritis	9.07e-06	9.38e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—BDKRB2—rheumatoid arthritis	9.07e-06	9.38e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—POMC—rheumatoid arthritis	9.01e-06	9.32e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ADRBK1—rheumatoid arthritis	8.97e-06	9.27e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CRP—rheumatoid arthritis	8.94e-06	9.24e-05	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—NFKB1—rheumatoid arthritis	8.93e-06	9.23e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IL2RA—rheumatoid arthritis	8.88e-06	9.18e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CCR5—rheumatoid arthritis	8.88e-06	9.18e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ACP5—rheumatoid arthritis	8.8e-06	9.09e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—B3GNT2—rheumatoid arthritis	8.8e-06	9.09e-05	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—MAPK8—rheumatoid arthritis	8.78e-06	9.08e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—MTHFR—rheumatoid arthritis	8.68e-06	8.97e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—HLA-A—rheumatoid arthritis	8.65e-06	8.94e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—POMC—rheumatoid arthritis	8.64e-06	8.93e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CXCL8—rheumatoid arthritis	8.62e-06	8.91e-05	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—VEGFA—rheumatoid arthritis	8.58e-06	8.87e-05	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—NFKB1—rheumatoid arthritis	8.58e-06	8.87e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—TLR4—rheumatoid arthritis	8.57e-06	8.86e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-DRB1—rheumatoid arthritis	8.56e-06	8.85e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—MMP1—rheumatoid arthritis	8.47e-06	8.76e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ALOX5—rheumatoid arthritis	8.47e-06	8.75e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—RASGRP1—rheumatoid arthritis	8.46e-06	8.75e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CCL2—rheumatoid arthritis	8.45e-06	8.74e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	8.45e-06	8.74e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SYK—rheumatoid arthritis	8.43e-06	8.72e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL6R—rheumatoid arthritis	8.43e-06	8.71e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—MED1—rheumatoid arthritis	8.29e-06	8.57e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PRKCQ—rheumatoid arthritis	8.28e-06	8.56e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL2—rheumatoid arthritis	8.24e-06	8.52e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—ICAM1—rheumatoid arthritis	8.22e-06	8.49e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL6ST—rheumatoid arthritis	8.22e-06	8.49e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—IL6—rheumatoid arthritis	8.2e-06	8.47e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—STAT1—rheumatoid arthritis	8.13e-06	8.41e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CXCL10—rheumatoid arthritis	8.02e-06	8.29e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—BGN—rheumatoid arthritis	7.92e-06	8.19e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD80—rheumatoid arthritis	7.91e-06	8.18e-05	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—TGFB1—rheumatoid arthritis	7.88e-06	8.14e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MMP9—rheumatoid arthritis	7.8e-06	8.06e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	7.76e-06	8.02e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—FN1—rheumatoid arthritis	7.73e-06	7.99e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—NFKB1—rheumatoid arthritis	7.71e-06	7.97e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—B3GNT2—rheumatoid arthritis	7.71e-06	7.97e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ACP5—rheumatoid arthritis	7.71e-06	7.97e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TYK2—rheumatoid arthritis	7.68e-06	7.93e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—NOS2—rheumatoid arthritis	7.64e-06	7.9e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IL6ST—rheumatoid arthritis	7.59e-06	7.84e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MAPK8—rheumatoid arthritis	7.58e-06	7.84e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NOS3—rheumatoid arthritis	7.54e-06	7.79e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—NOS2—rheumatoid arthritis	7.53e-06	7.78e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL6—rheumatoid arthritis	7.49e-06	7.74e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL6R—rheumatoid arthritis	7.33e-06	7.58e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MMP3—rheumatoid arthritis	7.31e-06	7.56e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CD80—rheumatoid arthritis	7.3e-06	7.55e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ALOX5—rheumatoid arthritis	7.29e-06	7.54e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	7.24e-06	7.49e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—TGFB1—rheumatoid arthritis	7.12e-06	7.35e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	7.1e-06	7.33e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PTK2—rheumatoid arthritis	7.04e-06	7.28e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—VEGFA—rheumatoid arthritis	7e-06	7.24e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—BGN—rheumatoid arthritis	6.94e-06	7.17e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—IL6—rheumatoid arthritis	6.92e-06	7.15e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCL5—rheumatoid arthritis	6.9e-06	7.13e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ENO1—rheumatoid arthritis	6.9e-06	7.13e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CAT—rheumatoid arthritis	6.87e-06	7.1e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	6.85e-06	7.08e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CSF2—rheumatoid arthritis	6.8e-06	7.03e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IL6R—rheumatoid arthritis	6.77e-06	7e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CXCL8—rheumatoid arthritis	6.68e-06	6.91e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—TYK2—rheumatoid arthritis	6.68e-06	6.9e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	6.44e-06	6.66e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TGFB1—rheumatoid arthritis	6.43e-06	6.64e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	6.41e-06	6.63e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SPP1—rheumatoid arthritis	6.39e-06	6.61e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ALOX5—rheumatoid arthritis	6.39e-06	6.6e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL2—rheumatoid arthritis	6.39e-06	6.6e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	6.39e-06	6.6e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	6.27e-06	6.48e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GC—rheumatoid arthritis	6.27e-06	6.48e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IFNG—rheumatoid arthritis	6.25e-06	6.46e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCR5—rheumatoid arthritis	6.22e-06	6.43e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—TYK2—rheumatoid arthritis	6.17e-06	6.37e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—NOS3—rheumatoid arthritis	6.14e-06	6.35e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL2RA—rheumatoid arthritis	6.13e-06	6.33e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—C3—rheumatoid arthritis	6.08e-06	6.28e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—NOS3—rheumatoid arthritis	6.05e-06	6.26e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MMP9—rheumatoid arthritis	6.05e-06	6.25e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD4—rheumatoid arthritis	6.04e-06	6.24e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NFKB1—rheumatoid arthritis	5.98e-06	6.18e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ENO1—rheumatoid arthritis	5.94e-06	6.14e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MAPK8—rheumatoid arthritis	5.88e-06	6.08e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	5.83e-06	6.02e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—MTHFR—rheumatoid arthritis	5.74e-06	5.93e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—LEP—rheumatoid arthritis	5.66e-06	5.85e-05	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IL6—rheumatoid arthritis	5.61e-06	5.8e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL1B—rheumatoid arthritis	5.58e-06	5.77e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CD4—rheumatoid arthritis	5.58e-06	5.76e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL2—rheumatoid arthritis	5.56e-06	5.74e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PTGS2—rheumatoid arthritis	5.54e-06	5.72e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—VEGFA—rheumatoid arthritis	5.43e-06	5.61e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—IL6—rheumatoid arthritis	5.36e-06	5.54e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FN1—rheumatoid arthritis	5.33e-06	5.51e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6ST—rheumatoid arthritis	5.31e-06	5.49e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TP53—rheumatoid arthritis	5.29e-06	5.47e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ENO1—rheumatoid arthritis	5.21e-06	5.38e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IL2—rheumatoid arthritis	5.21e-06	5.38e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—NFKB1—rheumatoid arthritis	5.2e-06	5.38e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—MAPK8—rheumatoid arthritis	5.11e-06	5.29e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CD80—rheumatoid arthritis	5.11e-06	5.29e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	5.11e-06	5.29e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—MED1—rheumatoid arthritis	5.11e-06	5.28e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TGFB1—rheumatoid arthritis	4.98e-06	5.15e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CAT—rheumatoid arthritis	4.97e-06	5.13e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	4.87e-06	5.03e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—POMC—rheumatoid arthritis	4.86e-06	5.02e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL6—rheumatoid arthritis	4.84e-06	5.01e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCL2—rheumatoid arthritis	4.75e-06	4.91e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	4.75e-06	4.91e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	4.75e-06	4.91e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6R—rheumatoid arthritis	4.74e-06	4.9e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—POMC—rheumatoid arthritis	4.59e-06	4.74e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—VEGFA—rheumatoid arthritis	4.43e-06	4.57e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TYK2—rheumatoid arthritis	4.32e-06	4.46e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CAT—rheumatoid arthritis	4.28e-06	4.42e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—BGN—rheumatoid arthritis	4.28e-06	4.42e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NOS3—rheumatoid arthritis	4.24e-06	4.38e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ALB—rheumatoid arthritis	4.18e-06	4.32e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—MTHFR—rheumatoid arthritis	4.15e-06	4.29e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TP53—rheumatoid arthritis	4.1e-06	4.24e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TGFB1—rheumatoid arthritis	4.06e-06	4.2e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—TGFB1—rheumatoid arthritis	4e-06	4.14e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—NOS3—rheumatoid arthritis	4e-06	4.13e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	3.94e-06	4.07e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CXCL8—rheumatoid arthritis	3.76e-06	3.89e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL6—rheumatoid arthritis	3.75e-06	3.88e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CAT—rheumatoid arthritis	3.75e-06	3.87e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PTGS2—rheumatoid arthritis	3.66e-06	3.78e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL2—rheumatoid arthritis	3.59e-06	3.71e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—MTHFR—rheumatoid arthritis	3.57e-06	3.69e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MMP9—rheumatoid arthritis	3.4e-06	3.51e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NFKB1—rheumatoid arthritis	3.36e-06	3.48e-05	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TP53—rheumatoid arthritis	3.34e-06	3.46e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—POMC—rheumatoid arthritis	3.32e-06	3.43e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MAPK8—rheumatoid arthritis	3.31e-06	3.42e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL6—rheumatoid arthritis	3.27e-06	3.38e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	3.21e-06	3.32e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	3.13e-06	3.23e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—VEGFA—rheumatoid arthritis	3.05e-06	3.16e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ALB—rheumatoid arthritis	3.02e-06	3.12e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IL6—rheumatoid arthritis	3.02e-06	3.12e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—NOS3—rheumatoid arthritis	2.89e-06	2.99e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—POMC—rheumatoid arthritis	2.86e-06	2.95e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TGFB1—rheumatoid arthritis	2.8e-06	2.9e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PTGS2—rheumatoid arthritis	2.64e-06	2.73e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—POMC—rheumatoid arthritis	2.5e-06	2.59e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—NOS3—rheumatoid arthritis	2.49e-06	2.57e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CAT—rheumatoid arthritis	2.31e-06	2.39e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TP53—rheumatoid arthritis	2.31e-06	2.38e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ALB—rheumatoid arthritis	2.28e-06	2.36e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PTGS2—rheumatoid arthritis	2.28e-06	2.35e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—NOS3—rheumatoid arthritis	2.18e-06	2.26e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6—rheumatoid arthritis	2.11e-06	2.18e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	2e-06	2.06e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	1.93e-06	1.99e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—POMC—rheumatoid arthritis	1.54e-06	1.59e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ALB—rheumatoid arthritis	1.41e-06	1.45e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	1.34e-06	1.39e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	1.23e-06	1.27e-05	CbGpPWpGaD
